Genotyping Market To Rise At USD 37.1 Billion By 2024 : Grand View Research Inc.
San Francisco, 18 July 2019: The Report Genotyping Market Analysis By Product (Reagents And Kits, Instruments And Services), By Technology (PCR, Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray) By Application (Diagnostics, Drug Discovery And Development, Personalized Medicine, Academic Research, Agriculture), And Segment Forecasts, 2018 – 2024 The global genotyping market is expected to reach USD 37.1 billion by 2024 according to a new report by Grand View Research, Inc. The increasing demand for genotyping tests to evaluate drug efficacy and safety is one of the major drivers for the genotyping market. Genotyping tests are widely used in selecting a highly responsive, patient population subset against a specific drug candidate before initiating clinical trials. The rising need for affordable genotyping services coupled with the high demand for personalized medicines is also expected to propel the market growth. Major pharmaceutical companies are collabo